Kestra Medical Technologies Ltd

Insider sales by Kestra Medical CEO raise questions about valuation, but revenue growth and option holdings hint at future upside—watch the market for signals.

Kestra Medical’s insider sales spike: CEO Daniel sold 15k shares, amid a 63% revenue jump yet $34 M loss—what this means for investors and valuation.

Insider selling at Kestra Medical: CEO Daniel’s Rule 10b‑5‑1 trades, timing, and impact on stock volatility and investor strategy.